Is small intestinal bacterial overgrowth linked to impaired intestinal motility and bloating?

Small intestinal bacterial overgrowth (SIBO) is a complex clinical condition characterized by abnormal bacterial proliferation in the small bowel, driving diverse gastrointestinal symptoms and altered motility patterns.

Motility dysregulation and mechanistic feedback

• Bidirectional dysmotility: SIBO is strongly linked to impaired motility, particularly migrating motor complex (MMC) phase III deficiency. When this "intestinal housekeeper" fails due to autonomic or enteric neuropathies, the resulting stasis permits bacterial colonization.
• Myoelectric inhibition: Overgrowth-derived gases, particularly methane, directly inhibit smooth-muscle contractility. This slows transit, worsening motility in a self-perpetuating feedback loop.

Symptom generation and gas dynamics

• Bloating and alternating bowel habits: Bacterial fermentation of dietary carbohydrates yields hydrogen, carbon dioxide, and methane, raising intraluminal pressure to cause bloating. Hydrogen-producing taxa promote diarrhea, while methanogenic archaea (Methanobrevibacter smithii) generate methane, slowing transit to cause constipation. Alternating bowel habits mirror shifts between these microbial populations.
• Incomplete evacuation: Though not a classic symptom, incomplete evacuation is a plausible consequence of methane-producing Intestinal Methanogen Overgrowth (IMO), which impairs motility and promotes constipation and gas retention.

Upper-gut microbial translocation

• Streptococcal overgrowth: When protective barriers fail—such as reduced gastric acid from proton pump inhibitors, impaired bile, or dysmotility—oral-type taxa like Streptococcus translocate. This small intestinal oral bacterial overgrowth (SIOBO) phenotype is driven by species like Streptococcus salivarius (linked to nutrient malabsorption in pediatric cohorts) rather than classic coliforms.

Bottom line

SIBO is intimately linked to impaired motility (MMC phase III deficiency) and drives bloating and alternating bowel habits via specific microbial gases, while also manifesting as an oral-type phenotype (Streptococcus overgrowth) when physiological barriers are compromised.